Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial

To see complete record on, please visit this link

Id: NCT05639322

Organisation Name: Unity Health Toronto

Overal Status: Not yet recruiting

Start Date: January 15, 2023

Last Update: December 6, 2022

Lead Sponsor: Akash Goel

Brief Summary: The purpose of the study is to investigate new therapies to alleviate pain on neuropathic chronic pain. At this time, the main purpose is to complete a feasibility or pilot study with 60 participants suffering from neuropathic chronic pain. Participants will be randomized to (1) Ketamine HL; (2) psychotherapy (using Cognitive Behavioral Therapy); or (3) a combination of Ketamine HL and psychotherapy.

  • Neuropathic Pain

Total execution time in seconds: 0.19993686676025